Summary:
A study to evaluate the effectiveness of an investigational medication in type 2 diabetics.
Qualified Participants Must:
• 18 years of age or older
•
Have a diagnosis of type 2 diabetes
•
Have an HbA1c value of 6.5% to 10.0%
•
Currently on a GLP-1 (Byetta, Bydureon, Tanzeum, Trulicity, or Victoza)
Qualified Participants May Receive:
- Reimbursement for time and travel
- Study-related care and study medicine at no cost (no health insurance required)